United Kingdom  Video

“Britain's speediest news portal”
One News Page
> >

U.S. FDA approves biosimilar version of cancer drug Avastin

Reuters Thursday, 14 September 2017
(Reuters) - The U.S. Food and Drug Administration said on Thursday it has approved Amgen Inc's biosimilar version of Roche Holding AG's cancer drug Avastin.
0
shares
Share on
Facebook
Share on
Twitter
Post on 
Reddit
Share by
Email
 
Source: RTV6 The Indy Channel - < > Embed
News video: Drug tested to lessen chemo side effects at IU Health

▶ Drug tested to lessen chemo side effects at IU Health 01:39

With a $2.9 million grant, the IU Cancer Center has begun testing a new drug to lessen the side effects of chemotherapy. Doctors at the Simon Cancer Center are looking to develop the drug to help cancer patients.

You Might Like


Tweets about this


Other recent news in Health

Public health officials warn of possible measles exposure on Air CANADA flightDid Pox Virus RESEARCH Put Potential Profits Ahead of Public Safety?
Severity of H3N2 flu strain raises concerns about viral MUTATIONS
Environmentally friendly: One News Page is hosted on servers powered solely by renewable energy
© 2018 One News Page Ltd. All Rights Reserved.  |  About us  |  Disclaimer  |  Press Room  |  Terms & Conditions  |  Privacy Policy  |  Content Accreditation
 RSS  |  News for my Website  |  Free news search widget  |  Help  |  Contact us  |  DMCA / Content Removal
How are we doing? Send us your feedback  |   LIKE us on Facebook   FOLLOW us on Twitter   FIND us on Google+